1. Home
  2. ULBI vs IPHA Comparison

ULBI vs IPHA Comparison

Compare ULBI & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ultralife Corporation

ULBI

Ultralife Corporation

HOLD

Current Price

$6.52

Market Cap

97.6M

Sector

Miscellaneous

ML Signal

HOLD

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

HOLD

Current Price

$1.28

Market Cap

119.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ULBI
IPHA
Founded
1990
1999
Country
United States
France
Employees
N/A
174
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.6M
119.1M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
ULBI
IPHA
Price
$6.52
$1.28
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.75
AVG Volume (30 Days)
69.4K
17.5K
Earning Date
03-10-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$191,159,000.00
N/A
Revenue This Year
$20.00
$181.17
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.24
N/A
52 Week Low
$4.07
$1.18
52 Week High
$9.51
$2.63

Technical Indicators

Market Signals
Indicator
ULBI
IPHA
Relative Strength Index (RSI) 53.43 38.04
Support Level $6.43 $1.18
Resistance Level $7.24 $1.88
Average True Range (ATR) 0.41 0.09
MACD -0.01 -0.00
Stochastic Oscillator 48.34 29.41

Price Performance

Historical Comparison
ULBI
IPHA

About ULBI Ultralife Corporation

Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

Share on Social Networks: